Books in Pharmaceutical biotechnology

11-18 of 18 results in All results

Remington

• 23rd Edition
• October 30, 2020
• Adeboye Adejare
• English
• Hardback 978-0-12-820007-0

  9 7 8 - 0 - 1 2 - 8 2 0 0 0 7 - 0
• eBook 978-0-12-822389-5

  9 7 8 - 0 - 1 2 - 8 2 2 3 8 9 - 5

The PCP's Bicentennial Edition Remington: The Science and Practice of Pharmacy, Twenty Third Edition, offers a trusted, completely updated source of information for education, training, and development of pharmacists. Published for the first time with Elsevier, this edition includes coverage of biologics and biosimilars as uses of those therapeutics have increased substantially since the previous edition. Also discussed are formulations, drug delivery (including prodrugs, salts, polymorphism. With clear, detailed color illustrations, fundamental information on a range of pharmaceutical science areas, and information on new developments in industry, pharmaceutical industry scientists, especially those involved in drug discovery and development will find this edition of Remington an essential reference. Intellectual property professionals will also find this reference helpful to cite in patents and resulting litigations. Additional graduate and postgraduate students in Pharmacy and Pharmaceutical Sciences will refer to this book in courses dealing with medicinal chemistry and pharmaceutics.

Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer

• 1st Edition
• January 26, 2019
• Prashant Kesharwani
• English
• Paperback 978-0-12-815720-6

  9 7 8 - 0 - 1 2 - 8 1 5 7 2 0 - 6
• eBook 978-0-12-816367-2

  9 7 8 - 0 - 1 2 - 8 1 6 3 6 7 - 2

Nanotechnology-based Targeted Drug Delivery Systems for Lung Cancer is an indispensable resource that will help pharmaceutical scientists and clinical researchers design and develop novel drug delivery systems and devices for the treatment of lung cancer. As recent breakthroughs in nanomedicine are now making it possible to deliver drugs, genes and therapeutic agents to localized areas of disease to maximize clinical benefit, while also limiting unwanted side effects, this book explores promising approaches for the diagnosis and treatment of lung cancer using cutting-edge nanomedical technologies. Topics discussed include polymeric nanoparticles, solid lipid nanoparticles, liposomes, dendrimers, micelles and nanoemulsions.

Pharmaceutical Medicine and Translational Clinical Research

• 1st Edition
• November 10, 2017
• Divya Vohora + 1 more
• English
• Paperback 978-0-12-802103-3

  9 7 8 - 0 - 1 2 - 8 0 2 1 0 3 - 3
• eBook 978-0-12-802098-2

  9 7 8 - 0 - 1 2 - 8 0 2 0 9 8 - 2

Pharmaceutical Medicine and Translational Clinical Research covers clinical testing of medicines and the translation of pharmaceutical drug research into new medicines, also focusing on the need to understand the safety profile of medicine and the benefit-risk balance. Pharmacoeconomics and the social impact of healthcare on patients and public health are also featured. It is written in a clear and straightforward manner to enable rapid review and assimilation of complex information and contains reader-friendly features.As a greater understanding of these aspects is critical for students in the areas of pharmaceutical medicine, clinical research, pharmacology and pharmacy, as well as professionals working in the pharmaceutical industry, this book is an ideal resource.

An Introduction to Ethical, Safety and Intellectual Property Rights Issues in Biotechnology

• 1st Edition
• June 21, 2017
• Padma Nambisan
• English
• Paperback 978-0-12-809231-6

  9 7 8 - 0 - 1 2 - 8 0 9 2 3 1 - 6
• eBook 978-0-12-809251-4

  9 7 8 - 0 - 1 2 - 8 0 9 2 5 1 - 4

An Introduction to Ethical, Safety and Intellectual Property Rights Issues in Biotechnology provides a comprehensive look at the biggest technologies that have revolutionized biology since the early 20th century, also discussing their impact on society. The book focuses on issues related to bioethics, biosafety and intellectual property rights, and is written in an easy-to-understand manner for graduate students and early career researchers interested in the opportunities and challenges associated with advances in biotechnology. Important topics covered include the Human Genome Project, human cloning, rDNA technology, the 3Rs and animal welfare, bioterrorism, human rights and genetic discrimination, good laboratory practices, good manufacturing practices, the protection of biological material and much more. Full of relevant case studies, practical examples, weblinks and resources for further reading, this book offers an essential and holistic look at the ways in which biotechnology has affected our global society.

The Funding of Biopharmaceutical Research and Development

• 1st Edition
• October 31, 2013
• David R Williams
• English
• eBook 978-1-908818-38-6

  9 7 8 - 1 - 9 0 8 8 1 8 - 3 8 - 6

The funding of biopharmaceutical research and development provides a comprehensive critical review of the funding of research and development (R&D) in the human biopharmaceutical market sector. It addresses both private and public funding sources available in the US and internationally. The biopharmaceutical market is among the most research-intensive market sectors globally. Clinical researchers face a multitude of public and private funding options with respect to bringing their idea or innovation to market. These funding options are continually changing and complex, and are expected to decrease in the near future. A lack of understanding of the scale, scope, and inner workings of the funding aspects of R&D can, at times, act as a barrier for all involved, and can slow down or even eliminate the R&D process. The book lessens these barriers by describing the theoretical underpinnings, present practice, and trends in R&D funding in this market sector, both in the US and internationally. This includes a review and discussion of public-private partnership activity and their inner-workings, noting the complementary relationship between public and private funding. The book also contains an overview of the inner-workings of strategic alliance activity, including the advantages and disadvantages for each party. It goes on to provide an outline of venture capital activity, detailing the methods by which venture capital firms raise capital and are organized, a description of the venture capital-entrepreneur arrangement, and the effects of this arrangement. The book also presents an overview of the IPO process and the various fates of firms going public.

Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics

• 1st Edition
• June 27, 2013
• Lisa M. Plitnick + 1 more
• English
• Hardback 978-0-12-394810-6

  9 7 8 - 0 - 1 2 - 3 9 4 8 1 0 - 6
• eBook 978-0-12-394823-6

  9 7 8 - 0 - 1 2 - 3 9 4 8 2 3 - 6

Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics is a complete reference devoted to the nonclinical safety assessment of novel biopharmaceuticals, biosimilars, vaccines, cell and gene therapies and blood products. This book compares and contrasts these types of biologics with one another and with small molecule drugs, while incorporating the most current and essential international regulatory documents. Each section discusses a different type of biologic, as well as early characterization strategies, principles of study design, preclinical pharmacokinetics and pharmacodynamics and preclinical assays. An edited book that is authored by leading experts in the field, this comprehensive reference provides critical insights to all researchers involved in early through late stage biologics.

Actinomycetes in Biotechnology

• 1st Edition
• November 13, 2012
• Bozzano G Luisa
• English
• eBook 978-0-08-098433-9

  9 7 8 - 0 - 0 8 - 0 9 8 4 3 3 - 9

The actinomycetes are a group of bacteria well known as producers of antibiotics. With the advent of molecular biology they have become important to biotechnologists in the search for new antibiotics, vitamins, enzyme inhibitors, etc. They also play an important role in the biodegradation of wastes, and their wide (natural) distribution in soil, composts, water and elsewhere in the environment makes them important to the agricultural and waste industries. This research book presents a broad view of the current interest in actinomycetes, ranging from isolation/screening of actinomycetes, discovery of new antibiotics, a substantial contribution on genetic manipulation to actinomycetes in agriculture, forestry, and the threat of actinomycetes as pollutants in the environment.The chapters, which have been written by experts, are intended to provide a balanced view of the opportunities and problems in an expanding field of interest.

Natural-Based Polymers for Biomedical Applications

• 1st Edition
• August 15, 2008
• Rui L. Reis + 5 more
• English
• eBook 978-1-84569-481-4

  9 7 8 - 1 - 8 4 5 6 9 - 4 8 1 - 4

Polymers from natural sources are particularly useful as biomaterials and in regenerative medicine, given their similarity to the extracellular matrix and other polymers in the human body. This important book reviews the wealth of research on both tried and promising new natural-based biomedical polymers, together with their applications as implantable biomaterials, controlled-release carriers or scaffolds for tissue engineering.The first part of the book reviews the sources, processing and properties of natural-based polymers for biomedical applications. Part two describes how the surfaces of polymer-based biomaterials can be modified to improve their functionality. The third part of the book discusses the use of natural-based polymers for biodegradable scaffolds and hydrogels in tissue engineering. Building on this foundation, Part four looks at the particular use of natural-gelling polymers for encapsulation, tissue engineering and regenerative medicine. The penultimate group of chapters reviews the use of natural-based polymers as delivery systems for drugs, hormones, enzymes and growth factors. The final part of the book summarises research on the key issue of biocompatibility.Natural-based polymers for biomedical applications is a standard reference for biomedical engineers, those studying and researching in this important area, and the medical community.